EMBEDA - 16590-897-30 - (MORPHINE SUFATE)

Alphabetical Index


Drug Information of EMBEDA

Product NDC: 16590-897
Proprietary Name: EMBEDA
Non Proprietary Name: MORPHINE SUFATE
Active Ingredient(s): 20; .8    mg/1; mg/1 & nbsp;   MORPHINE SUFATE
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of EMBEDA

Product NDC: 16590-897
Labeler Name: STAT RX USA LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022321
Marketing Category: NDA
Start Marketing Date: 20090813

Package Information of EMBEDA

Package NDC: 16590-897-30
Package Description: 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16590-897-30)

NDC Information of EMBEDA

NDC Code 16590-897-30
Proprietary Name EMBEDA
Package Description 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16590-897-30)
Product NDC 16590-897
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name MORPHINE SUFATE
Dosage Form Name CAPSULE, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20090813
Marketing Category Name NDA
Labeler Name STAT RX USA LLC
Substance Name MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
Strength Number 20; .8
Strength Unit mg/1; mg/1
Pharmaceutical Classes Full Opioid Agonists [MoA],Opioid Agonist [EPC],Opioid Antagonist [EPC],Opioid Antagonists [MoA]

Complete Information of EMBEDA


General Information